Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-07

Clinical Trial Update: Effect of Albumin-bound Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Patients Receiving Neoadjuvant Chemotherapy for Advanced Ovarian, Fallopian Tube or Peritoneal Cancer: A Phase 2 Single Center Clinical Trial [Phase 2]

View source ↗

Summary

Phase 2 trial comparing albumin-bound paclitaxel plus carboplatin vs paclitaxel plus carboplatin in neoadjuvant setting for advanced ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albumin-bound paclitaxel (nab-paclitaxel)
  • CARBOPLATIN (Carboplatin)
  • PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Ovarian Cancer | Phase 2 | Status: UNKNOWN